ADHD is a generally persistent neurodevelopmental condition that can have significant consequences if left untreated, and medication, often in conjunction with psychotherapy, is the first-line treatment with well-established efficacy. Adolescents and young adults (AYAs) represent a particularly vulnerable and understudied subgroup and there remains a significant concern regarding transition to treatment independence, treatment engagement and medication adherence in this population. We report the results from a pilot trial evaluating Customized Adherence Enhancement-ADHD (CAE-ADHD), a psychosocial intervention for AYAs with ADHD, aimed to increase independence in managing ADHD and improve ADHD symptoms.
Methods:
We used an iterative process to modify an existing psychosocial intervention to address engagement, independence, and adherence in AYAs with ADHD, originally developed for AYAs with bipolar disorder. To develop the CAE-ADHD intervention, we conducted focus groups and cognitive interviews with AYA with ADHD. We then conducted a pilot feasibility and efficacy study in AYAs with ADHD (n = 12) with follow-up visits at 8 and 12 weeks into the study.
Results:
The sample consisted of 12 participants ages 16 to 24 years with a diagnosis of ADHD, obtained via self-report, and currently prescribed stimulant medication. Mean age of the sample was 19.5 years, 58.33% female, 25% non-White. Participation and retention were strong with 93.33% of sessions completed overall and 10/12 participants completing all sessions. AYAs showed a trend toward improvement in ADHD symptoms as measured by the ADHD RS-5, statistically significant improvement in transition readiness and ADHD knowledge. There was no significant change in adherence.
Conclusions:
This first of its kind feasibility and efficacy pilot study for a novel intervention, CAE-ADHD, found high engagement and improvement in ADHD symptoms, transition readiness, and ADHD knowledge from baseline to week 12.
AbdallahS.ChurchE.Kamimura-NishimuraK.LevinJ.GrayM.YalaJ.McVoyM. (2023). Thematic analysis of focus groups in the development of a Customized Adherence Enhancement (CAE) treatment intervention [Paper presentation]. 57th annual meeting of the Association for Behavioral and Cognitive Therapies, Seattle, WA, 2023.
2.
AbdallahS.ChurchE.LevinJ. B.ChelaA.McVoyM. (2024). Short- and long-term outcomes of suboptimal medication adherence in adolescents with attention-deficit/hyperactivity disorder: A systematic literature review. Journal of Child and Adolescent Psychopharmacology, 34(4), 183–193. https://doi.org/10.1089/cap.2024.0018
3.
AlwadiyF.MokE.DasguptaK.RahmeE.FreiJ.NakhlaM. (2021). Association of self-efficacy, transition readiness and diabetes distress with glycemic control in adolescents with type 1 diabetes preparing to transition to adult care. Canadian Journal of Diabetes, 45(5), 490–495. https://doi.org/10.1016/j.jcjd.2021.05.006
4.
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev).
5.
Barnard-BrakL.RobertsB.ValenzuelaE. (2020). Examining breaks and resistance in medication adherence among adolescents with ADHD as associated with school outcomes. Journal of Attention Disorders, 24(8), 1148–1155. https://doi.org/10.1177/1087054718763738
6.
Bevan JonesR.ThaparA.StoneZ.JonesI.SmithD.SimpsonS. (2018). Psychoeducational interventions in adolescent depression: A systematic review. Patient Education and Counseling, 101(5), 804–816. https://doi.org/10.1016/j.pec.2017.10.015
7.
BiedermanJ.PettyC. R.ClarkeA.LomedicoA.FaraoneS. V. (2011). Predictors of persistent ADHD: An 11-year follow-up study. Journal of Psychiatric Research, 45(2), 150–155. https://doi.org/10.1016/j.jpsychires.2010.06.009
8.
Bihlar MuldB.JokinenJ.BölteS.HirvikoskiT. (2015). Long-term outcomes of pharmacologically treated versus non-treated adults with ADHD and substance use disorder: A naturalistic study. Journal of Substance Abuse Treatment, 51, 82–90. https://doi.org/10.1016/j.jsat.2014.11.005
9.
BuizzaC.CandiniV.FerrariC.GhilardiA.SaviottiF. M.TurrinaC.NobiliG.SabaudoM.de GirolamoG. (2019). The long-term effectiveness of psychoeducation for bipolar disorders in mental health services. A 4-year follow-up study. Frontiers in Psychiatry, 10, Article 873. https://doi.org/10.3389/fpsyt.2019.00873
10.
CastellsX.RamonM.CunillR.OlivéC.SerranoD. (2021). Relationship between treatment duration and efficacy of pharmacological treatment for ADHD: A meta-analysis and meta-regression of 87 randomized controlled clinical trials. Journal of Attention Disorders, 25(10), 1352–1361. https://doi.org/10.1177/1087054720903372
11.
Catalá-LópezF.HuttonB.Núñez-BeltránA.PageM. J.RidaoM.Macías Saint-GeronsD.CataláM. A.Tabarés-SeisdedosR.MoherD. (2017). The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLoS ONE, 12(7), e0180355. https://doi.org/10.1371/journal.pone.0180355
12.
CharachA.FernandezR. (2013). Enhancing ADHD medication adherence: Challenges and opportunities. Current Psychiatry Reports, 15(7), 371. https://doi.org/10.1007/s11920-013-0371-6
13.
CleverleyK.DaviesJ.AllemangB.BrennenstuhlS. (2023). Validation of the Transition Readiness Assessment Questionnaire (TRAQ) 5.0 for use among youth in mental health services. Child: Care, Health and Development, 49(2), 248–257. https://doi.org/10.1111/cch.13035
14.
CorteseS.AdamoN.Del GiovaneC.Mohr-JensenC.HayesA. J.CarucciS.AtkinsonL. Z.TessariL.BanaschewskiT.CoghillD.HollisC.SimonoffE.ZuddasA.BarbuiC.PurgatoM.SteinhausenH. C.ShokranehF.XiaJ.CiprianiA. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. Lancet Psychiatry, 5(9), 727–738. https://doi.org/10.1016/s2215-0366(18)30269-4
15.
DahlV.RamakrishnanA.SpearsA. P.JorgeA.LuJ.BigioN. A.ChackoA. (2020). Psychoeducation interventions for parents and teachers of children and adolescents with ADHD: A systematic review of the literature. Journal of Developmental and Physical Disabilities, 32, 257–292.
16.
DelBelloM.LevinJ.ModiA.ForthumL.McVoyM.BriggsF.SajatovicM. (2021). Psychopharmacological importance of medication adherence among adolescents with bipolar disorder [Paper presentation]. American Academy of Child and Adolescent Psychiatry 68th Annual Meeting, Atlanta, GA, October 2021.
17.
DolanN.Simmonds-BuckleyM.KellettS.SiddellE.DelgadilloJ. (2021). Effectiveness of stress control large group psychoeducation for anxiety and depression: Systematic review and meta-analysis. British Journal of Clinical Psychology, 60(3), 375–399. https://doi.org/10.1111/bjc.12288
18.
DuPaulG. J.PowerT. J.AnastopoulosA. D.ReidR. (2016). ADHD Rating Scale—5 for children and adolescents. Checklists, norms, and clinical interpretation. Guilford Press.
19.
FariesD. E.YalcinI.HarderD.HeiligensteinJ. H. (2001). Validation of the ADHD rating scale as a clirlician administered and scored instrument. Journal of Attention Disorders, 5(2), 107–115.
20.
FordT. (2020). Transitional care for young adults with ADHD: Transforming potential upheaval into smooth progression. Epidemiology and Psychiatric Sciences, 29, e87. https://doi.org/10.1017/S2045796019000817
21.
ForthunL. F.SajatovicM.LevinJ. B.DelBelloM. P.ApplingD.BroadnaxM. D.Fuentes-CasianoE.CooleyR.BlixenC. E.ModiA. C. (2023). Modification of an intervention to improve adherence in adolescents and young adults with bipolar disorder. JAACAP Open, 1(2), 80–92. https://doi.org/https://doi.org/10.1016/j.jaacop.2023.04.001
22.
GauS. S.ChenS. J.ChouW. J.ChengH.TangC. S.ChangH. L.TzangR. F.WuY. Y.HuangY. F.ChouM. C.LiangH. Y.HsuY. C.LuH. H.HuangY. S. (2008). National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. The Journal of Clinical Psychiatry, 69(1), 131–140. https://doi.org/10.4088/jcp.v69n0118
23.
GauciJ.BloomfieldJ.LawnS.TownsS.SteinbeckK. (2021). Effectiveness of self-management programmes for adolescents with a chronic illness: A systematic review. Journal of Advanced Nursing, 77(9), 3585–3599. https://doi.org/10.1111/jan.14801
24.
HanghøjS.BoisenK. A. (2014). Self-reported barriers to medication adherence among chronically ill adolescents: A systematic review. Journal of Adolescent Health, 54(2), 121–138. https://doi.org/10.1016/j.jadohealth.2013.08.009
25.
HarrisP. A.TaylorR.ThielkeR.PayneJ.GonzalezN.CondeJ. G. (2009). Research electronic data capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010
26.
HeppS. L. (2009). A psychometric examination of the knowledge of ADHD scale. Diss. University of Saskatchewan.
27.
Kamimura-NishimuraK. I.BrinkmanW. B.FroehlichT. E. (2019). Strategies for improving ADHD medication adherence. Current Psychiatry Reports, 18(8), 25–38.
28.
KhanM. U.HasanS. S. (2024). Phase-specific strategies and interventions to enhance medication adherence across different phases in ADHD: A systematic review and meta-analysis. Expert Review of Neurotherapeutics, 24(7), 711–722. https://doi.org/10.1080/14737175.2024.2360118
29.
KlassenA. F.GrantC.BarrR.BrillH.Kraus de CamargoO.RonenG. M.SamaanM. C.MondalT.CanoS. J.SchlatmanA.TsangarisE.AthaleU.WickertN.GorterJ. W. (2015). Development and validation of a generic scale for use in transition programmes to measure self-management skills in adolescents with chronic health conditions: The TRANSITION-Q. Child: Care, Health and Development, 41(4), 547–558. https://doi.org/10.1111/cch.12207
30.
LevinJ. B.BriggsF.BlixenC.BauerM.EinstadterD.AlbertJ. M.WeiseC.WoodsN.Fuentes-CasianoE.CassidyK. A.RentschJ.SarnaK.SajatovicM. (2022). A randomized controlled trial of customized adherence enhancement (CAE-E): Study protocol for a hybrid effectiveness-implementation project. Trials, 23(1), 634. https://doi.org/10.1186/s13063-022-06517-0
31.
LevinJ.DelBelloM.ModiA.McVoyM.BriggsF.ForthunL.CooleyR.BlackJ.ConroyC.SajatovicM. (2024). A 6-month, prospective, randomized controlled trial of customized adherence enhancement versus bipolar-specific educational control in poorly adherent adolescents and young adults living with bipolar disorder [Paper presentation]. American Academy of Child and Adolescent Psychiatry (AACAP)2024 Annual Meeting, Seattle, WA, October2024.
32.
MarianS.ArantxaG.NekaneB. (2013). Review of tools used for assessing teachers’ level of knowledge with regards attention deficit hyperactivity disorder (ADHD). In SomnathB. (Ed.), Attention deficit hyperactivity disorder in children and adolescents (pp. Ch. 8). IntechOpen.
33.
McVoyM.DelbelloM.LevinJ.ModiA. C.ForthunL. F.BriggsF.ApplingD.BroadnaxM.ConroyC.CooleyR.EapenG.SajatovicM. (2022). A customized adherence enhancement program for adolescents and young adults with suboptimal adherence and bipolar disorder: Trial design and methodological report. Contemporary Clinical Trials, 115, Article 106729. https://doi.org/10.1016/j.cct.2022.106729
34.
McVoyM.LevinJ. B. (2023). Updated strategies for the management of poor medication adherence in patients with bipolar disorder. Expert Review of Neurotherapeutics, 23(4), 365–376. https://doi.org/10.1080/14737175.2023.2198704
35.
MontoyaA.ColomF.FerrinM. (2011). Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review. European Psychiatry, 26(3), 166–175. https://doi.org/10.1016/j.eurpsy.2010.10.005
36.
OgundeleM. O.AyyashH. F. (2023). ADHD in children and adolescents: Review of current practice of non-pharmacological and behavioural management. AIMS Public Health, 10(1), 35–51. https://doi.org/10.3934/publichealth.2023004
37.
RimalR. N. (2000). Closing the knowledge-behavior gap in health promotion: The mediating role of self-efficacy. Health Communication, 12(3), 219–237. https://doi.org/10.1207/s15327027hc1203_01
38.
RosenD.AnnunziatoR.ColombelJ. F.DubinskyM.BenkovK. (2016). Transition of inflammatory bowel disease care: Assessment of transition readiness factors and disease outcomes in a young adult population. Inflammatory Bowel Disease, 22(3), 702–708. https://doi.org/10.1097/mib.0000000000000633
39.
SajatovicM.LevinJ. B.ModiA.McVoyM.ForthunL. F.CooleyR.BlackJ.ConroyC.SarnaK.BriggsF. B.BriggsF. B. (2023). Association between symptom severity and medication adherence in adolescents with bipolar disorder demonstrating suboptimal adherence. Psychopharmacol Bull, 53(3), 8–21.
40.
SajatovicM.LevinJ.TatsuokaC.Micula-GondekW.Fuentes-CasianoE.BialkoC. S.CassidyK. A. (2012). Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder. Bipolar Disorder, 14(3), 291–300. https://doi.org/10.1111/j.1399-5618.2012.01010.x
41.
SajatovicM.TatsuokaC.CassidyK. A.KleinP. J.Fuentes-CasianoE.CageJ.AebiM. E.RamirezL. F.BlixenC.PerzynskiA. T.BauerM. S.SafrenS. A.LevinJ. B. (2018). A 6-month, prospective, randomized controlled trial of customized adherence enhancement versus bipolar-specific educational control in poorly adherent individuals with bipolar disorder. The Journal of Clinical Psychiatry, 79(6), 17m12036. https://doi.org/10.4088/JCP.17m12036
42.
SalariN.GhasemiH.AbdoliN.RahmaniA.ShiriM. H.HashemianA. H.AkbariH.MohammadiM. (2023). The global prevalence of ADHD in children and adolescents: A systematic review and meta-analysis. Italian Journal of Pediatrics, 49(1), 48. https://doi.org/10.1186/s13052-023-01456-1
43.
SanabraM.Gómez-HinojosaT.GrauN.AldaJ. A. (2022). Deficient emotional self-regulation and sleep problems in ADHD with and without pharmacological treatment. Journal of Attention Disorders, 26(3), 426–433. https://doi.org/10.1177/1087054720986242
44.
SayalK.PrasadV.DaleyD.FordT.CoghillD. (2018). ADHD in children and young people: Prevalence, care pathways, and service provision. The Lancet Psychiatry, 5(2), 175–186. https://doi.org/10.1016/S2215-0366(17)30167-0
45.
ScarpelliniF.BonatiM. (2023). Transition care for adolescents and young adults with attention-deficit hyperactivity disorder (ADHD): A descriptive summary of qualitative evidence. Child: Care, Health and Development, 49(3), 431–443.
46.
SchermannH.GurelR.AnkoryR.KadarA.YoffeV.SnirN.SternheimA.KarakisI. (2018). Lower risk of fractures under methylphenidate treatment for ADHD: A dose-response effect. Journal of Orthopaedic Research, 36(12), 3328–3333. https://doi.org/10.1002/jor.24129
47.
ScottJ.PopeM. (2002). Nonadherence with mood stabilizers: Prevalence and predictors. The Journal of Clinical Psychiatry, 63(5), 384–390.
48.
SpencerT. J.FaraoneS. V.TarkoL.McDermottK.BiedermanJ. (2014). Attention-deficit/hyperactivity disorder and adverse health outcomes in adults. The Journal of Nervous and Mental Disease, 202(10), 725–731. https://doi.org/10.1097/nmd.0000000000000191
49.
TürkS.KorfmacherA. K.GergerH.van der OordS.ChristiansenH. (2023). Interventions for ADHD in childhood and adolescence: A systematic umbrella review and meta-meta-analysis. Clinical Psychology Review, 102, Article 102271. https://doi.org/10.1016/j.cpr.2023.102271
50.
TursiM. F.BaesC.CamachoF. R.TofoliS. M.JuruenaM. F. (2013). Effectiveness of psychoeducation for depression: A systematic review. Australian and New Zealand Journal of Psychiatry, 47(11), 1019–1031. https://doi.org/10.1177/0004867413491154
51.
TysonC.RobbA. (2021). Unexpected peaks and valleys: Navigating the path to adulthood with a mood disorder. In ChanV.DerenneJ. (Eds.), Transition-age youth mental health care: Bridging the gap between pediatric and adult psychiatric care (pp. 75–96). Springer Nature Switzerland AG.
52.
VarniJ. W.SeidM.KurtinP. S. (2001). PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Medical Care, 39(8), 800–812. https://doi.org/10.1097/00005650-200108000-00006
53.
VasiliadisH. M.LunghiC.RahmeE.RochetteL.GignacM.MassambaV.DialloF. B.FansiA.CorteseS.LesageA. (2024). ADHD medications use and risk of mortality and unintentional injuries: A population-based cohort study. Translational Psychiatry, 14(1), 128. https://doi.org/10.1038/s41398-024-02825-y
54.
VuoriM.Koski-PiriläA.MartikainenJ. E.SaastamoinenL. (2020). Gender- and age-stratified analyses of ADHD medication use in children and adolescents in Finland using population-based longitudinal data, 2008-2018. Scandinavian Journal of Public Health, 48(3), 303–307. https://doi.org/10.1177/1403494820901426
55.
WolraichM. L.HaganJ. F.Jr.AllanC.ChanE.DavisonD.EarlsM.EvansS. W.FlinnS. K.FroehlichT.FrostJ.HolbrookJ. R.LehmannC. U.LessinH. R.OkechukwuK.PierceK. L.WinnerJ. D.ZurhellenW. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of Attention-Deficit/Hyperactivity Disorder in children and adolescents. Pediatrics, 144(4), e20192528. https://doi.org/10.1542/peds.2019-2528
56.
WoodD. L.SawickiG. S.MillerM. D.SmothermanC.Lukens-BullK.LivingoodW. C.FerrisM.KraemerD. F. (2014). The Transition Readiness Assessment Questionnaire (TRAQ): Its factor structure, reliability, and validity. Academic Pediatrics, 14(4), 415–422. https://doi.org/10.1016/j.acap.2014.03.008
57.
WuF.ZhangW.JiW.ZhangY.JiangF.LiG.HuY.WeiX.WangH.WangS. A.ManzaP.TomasiD.VolkowN. D.GaoX.WangG. J.WangG. J. (2024). Stimulant medications in children with ADHD normalize the structure of brain regions associated with attention and reward. Neuropsychopharmacology, 49(8), 1330–1340. https://doi.org/10.1038/s41386-024-01831-4
